Public
- Public
- Network
- Groups
- Featured
- Popular
- People

Aids and HIV ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers As regulator prepares to approve lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

Download link

Aids and HIV ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers As regulator prepares to approve lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
https://cdn.masto.host/medmastodoncom/media_attachments/files/114/706/684/709/882/464/original/82a93d43147c225d.png

Notices where this attachment appears

Embed this notice
Dr. Lucky Tran :verified: (luckytran@med-mastodon.com)'s status on Thursday, 19-Jun-2025 07:35:04 JST Dr. Lucky Tran :verified:

Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.

In conversation about a year ago from med-mastodon.com permalink